Novartis Organizational Structure

Novartis Organizational Structure

ECN Members

Joerg Reinhardt

Chairman, Board of Directors

Charlotte Pamer-Wieser Corporate Secretary

Vas Narasimhan Chief Executive Officer

Elizabeth Doherty

Chairman, Audit and Compliance Committee

Steven Baert

Chief People & Organization Officer

Jay Bradner

President Novartis Institutes for BioMedical Research (NIBR)

Klaus Moosmayer

Chief Ethics, Risk and Compliance Officer

Richard Saynor

Chief Executive Officer Sandoz

Susanne Schaffert

President Novartis Oncology

Harry Kirsch Chief Financial Officer

Karen L. Hale

Chief Legal Officer as of May 15, 2021

Steffen Lang

Global Head Novartis Technical Operations

John Tsai

Head Global Drug Development & Chief Medical Officer

Marie-France Tschudin

President Novartis Pharmaceuticals

Robert Weltevreden

Head Customer & Technology Solutions (CTS)

Bertrand Bodson

Strategic Advisor to the Chief Executive Officer

Lutz Heggemann

Group Head Corporate Affairs and Global Health

Thomas N. Kendris

Ad interim Chief Legal Officer

Michael Willi

Chief Communications Officer, Communications & Engagement

Natacha Theytaz

Global Head Novartis Business Assurance & Advisory and Head Internal Audit

Updated: April 2021

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download